company background image
A253840 logo

Sugentech KOSDAQ:A253840 Stock Report

Last Price

₩5.11k

Market Cap

₩78.1b

7D

-3.8%

1Y

-37.4%

Updated

22 Dec, 2024

Data

Company Financials

A253840 Stock Overview

Develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. More details

A253840 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends1/6

My Notes

Capture your thoughts, links and company narrative

Sugentech Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Sugentech
Historical stock prices
Current Share Price₩5,110.00
52 Week High₩11,500.00
52 Week Low₩4,700.00
Beta-3.04
1 Month Change-9.07%
3 Month Change-14.69%
1 Year Change-37.38%
3 Year Change-62.84%
5 Year Change-6.24%
Change since IPO-18.24%

Recent News & Updates

Does Sugentech (KOSDAQ:253840) Have A Healthy Balance Sheet?

Jul 27
Does Sugentech (KOSDAQ:253840) Have A Healthy Balance Sheet?

Recent updates

Does Sugentech (KOSDAQ:253840) Have A Healthy Balance Sheet?

Jul 27
Does Sugentech (KOSDAQ:253840) Have A Healthy Balance Sheet?

We Like Sugentech's (KOSDAQ:253840) Returns And Here's How They're Trending

Apr 14
We Like Sugentech's (KOSDAQ:253840) Returns And Here's How They're Trending

Sugentech (KOSDAQ:253840) Seems To Use Debt Quite Sensibly

Mar 09
Sugentech (KOSDAQ:253840) Seems To Use Debt Quite Sensibly

If You Had Bought Sugentech (KOSDAQ:253840) Stock A Year Ago, You Could Pocket A 139% Gain Today

Feb 02
If You Had Bought Sugentech (KOSDAQ:253840) Stock A Year Ago, You Could Pocket A 139% Gain Today

Is Sugentech (KOSDAQ:253840) The Next Multi-Bagger?

Dec 29
Is Sugentech (KOSDAQ:253840) The Next Multi-Bagger?

Sugentech (KOSDAQ:253840) Seems To Use Debt Quite Sensibly

Dec 03
Sugentech (KOSDAQ:253840) Seems To Use Debt Quite Sensibly

Shareholder Returns

A253840KR Medical EquipmentKR Market
7D-3.8%-3.2%-3.7%
1Y-37.4%-3.0%-10.4%

Return vs Industry: A253840 underperformed the KR Medical Equipment industry which returned -3% over the past year.

Return vs Market: A253840 underperformed the KR Market which returned -10.4% over the past year.

Price Volatility

Is A253840's price volatile compared to industry and market?
A253840 volatility
A253840 Average Weekly Movement6.6%
Medical Equipment Industry Average Movement7.4%
Market Average Movement6.6%
10% most volatile stocks in KR Market12.7%
10% least volatile stocks in KR Market3.3%

Stable Share Price: A253840 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A253840's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2011145Sohn Misugentech.com

Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2, HbA1c, beta-hcg, YSH, T3/T4, and CRP; and digital health and home tests, including mobile health, ovulation, and pregnancy products.

Sugentech Inc. Fundamentals Summary

How do Sugentech's earnings and revenue compare to its market cap?
A253840 fundamental statistics
Market cap₩78.13b
Earnings (TTM)-₩12.11b
Revenue (TTM)₩9.71b

8.0x

P/S Ratio

-6.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A253840 income statement (TTM)
Revenue₩9.71b
Cost of Revenue₩9.50b
Gross Profit₩203.05m
Other Expenses₩12.31b
Earnings-₩12.11b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-792.09
Gross Margin2.09%
Net Profit Margin-124.76%
Debt/Equity Ratio4.5%

How did A253840 perform over the long term?

See historical performance and comparison

Dividends

2.9%

Current Dividend Yield

n/a

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 14:05
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sugentech Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution